Marker Therapeutics, Inc. (MRKR)
0.9466
-0.06
(-6.28%)
USD |
NASDAQ |
Oct 13, 16:00
0.9466
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics EPS Diluted (Quarterly) : -0.0946 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0946 |
| March 31, 2026 | -0.1646 |
| December 31, 2025 | -0.1022 |
| September 30, 2025 | -0.1193 |
| June 30, 2025 | -0.2877 |
| March 31, 2025 | -0.4003 |
| December 31, 2024 | -0.4217 |
| September 30, 2024 | -0.2587 |
| June 30, 2024 | -0.2459 |
| March 31, 2024 | -0.2688 |
| December 31, 2023 | -0.3079 |
| September 30, 2023 | -0.3379 |
| June 30, 2023 | -0.7136 |
| March 31, 2023 | -0.5696 |
| December 31, 2022 | -0.4591 |
| September 30, 2022 | -8.277 |
| June 30, 2022 | -1.106 |
| March 31, 2022 | -1.192 |
| December 31, 2021 | -1.276 |
| September 30, 2021 | -1.496 |
| June 30, 2021 | -1.314 |
| March 31, 2021 | -1.555 |
| December 31, 2020 | -1.760 |
| September 30, 2020 | -1.573 |
| June 30, 2020 | -1.362 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.407 |
| December 31, 2019 | -1.111 |
| September 30, 2019 | -1.196 |
| June 30, 2019 | -1.224 |
| March 31, 2019 | -1.170 |
| December 31, 2018 | -67.24 |
| September 30, 2018 | -3.195 |
| June 30, 2018 | -4.065 |
| March 31, 2018 | -3.009 |
| December 31, 2017 | -2.532 |
| September 30, 2017 | -3.90 |
| June 30, 2017 | -2.208 |
| March 31, 2017 | -2.871 |
| December 31, 2016 | -1.872 |
| September 30, 2016 | -2.90 |
| June 30, 2016 | 3.60 |
| March 31, 2016 | -8.40 |
| December 31, 2015 | -29.12 |
| September 30, 2015 | 3.60 |
| June 30, 2015 | -66.00 |
| March 31, 2015 | -4.80 |
| December 31, 2014 | -4.35 |
| September 30, 2014 | -10.80 |
| June 30, 2014 | 6.00 |
| March 31, 2014 | -514.80 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.826M |
| Total Expenses (Quarterly) | 1.826M |
| Enterprise Value | 4.918M |
| Earnings Yield | -50.78% |
| Normalized Earnings Yield | -50.77 |